We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+3.77%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$254M
AUM Growth
+$1.44M
Cap. Flow
-$4.03M
Cap. Flow %
-1.58%
Top 10 Hldgs %
41.46%
Holding
92
New
3
Increased
8
Reduced
56
Closed
2

Top Sells

Rank Stock Value
1
NVS icon
Novartis
NVS
+$1.34M
2
NKE icon
Nike
NKE
+$1.16M
3
NVDA icon
NVIDIA
NVDA
+$1.08M
4
AMD icon
Advanced Micro Devices
AMD
+$333K
5
CVS icon
CVS Health
CVS
+$291K

Sector Composition

Rank Sector Weight
1 Technology 31.77%
2 Healthcare 19.93%
3 Industrials 12.8%
4 Consumer Discretionary 9.06%
5 Consumer Staples 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
76
CVS Health
CVS
$137B
$277K 0.11%
4,695
-4,656
-50% -$291K
IP icon
77
International Paper
IP
$22.5B
$259K 0.1%
6,000
APD icon
78
Air Products & Chemicals
APD
$65.2B
$258K 0.1%
1,000
BRK.B icon
79
Berkshire Hathaway Class B
BRK.B
$1.07T
$244K 0.1%
600
CMCSA icon
80
Comcast
CMCSA
$80.9B
$227K 0.09%
5,800
WMT icon
81
Walmart Inc
WMT
$889B
$223K 0.09%
+3,300
New +$208K
SPY icon
82
State Street SPDR S&P 500 ETF Trust
SPY
$781B
$222K 0.09%
408
ALLE icon
83
Allegion
ALLE
$13.4B
$201K 0.08%
1,700
LLY icon
84
Eli Lilly
LLY
$1.07T
-349
Closed -$272K
PFE icon
85
Pfizer
PFE
$141B
-7,220
Closed -$200K

Similar funds

Notis-McConarty Edward's Q2 2024 Portfolio in Review

As of Q2 2024, Notis-McConarty Edward held 92 positions worth $254M, up 0.57% from $253M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Notis-McConarty Edward's Q2 2024 filing shows 3 new, 8 increased, 56 reduced and 2 closed positions. Its largest new stake was McCormick & Company Non-Voting: 10,945 shares worth $776K. The largest sale was Novartis, an estimated $1.34M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Industrials.

  • Notis-McConarty Edward's largest Q2 2024 buy was McCormick & Company Non-Voting: 10,945 shares worth $776K.
  • Notis-McConarty Edward added most to Vertex Pharmaceuticals in Q2 2024, an estimated $1.07M increase.
  • Notis-McConarty Edward's biggest Q2 2024 reduction was Novartis, cutting an estimated $1.34M.
  • Notis-McConarty Edward fully exited Eli Lilly in Q2 2024, selling an estimated $272K.
  • Notis-McConarty Edward's ten largest holdings make up 41% of its $254M portfolio in Q2 2024.
  • Notis-McConarty Edward opened 3 new positions and closed 2 in Q2 2024.
  • Notis-McConarty Edward's portfolio value rose 0.57% quarter-over-quarter to $254M.

Based on Notis-McConarty Edward's 13F filing for Q2 2024, filed 12 Aug 2024.